List of Clarus Therapeutics patents

List of Clarus Therapeutics patents

List of Volkswagen Aktiengesellschaft patents

List of Guidewire Software patents

List of Vascular Biogenics patents

List of funding rounds for ViZn Energy Systems

List of funding rounds for Retool

Patents where

Current Assignee

Name

is

Clarus Therapeutics

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11331325 Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same		Clarus Therapeutics	Clarus Therapeutics		United States Patent and Trademark Office	11331325	May 17, 2022
	‌ US Patent 8241664 Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same	Patent 8241664 was granted and assigned to Clarus Therapeutics on August, 2012 by the United States Patent and Trademark Office.		Clarus Therapeutics		United States Patent and Trademark Office	8241664	August 14, 2012
	‌ US Patent 11426416 Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same		Clarus Therapeutics	Clarus Therapeutics		United States Patent and Trademark Office	11426416	August 30, 2022
	‌ US Patent 10245273 Oral pharmaceutical products and methods of use combining testosterone esters with hypolipidemic agents	Patent 10245273 was granted and assigned to Clarus Therapeutics on April, 2019 by the United States Patent and Trademark Office.	Clarus Therapeutics	Clarus Therapeutics		United States Patent and Trademark Office	10245273	April 2, 2019
	‌ US Patent 8492369 Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same	Patent 8492369 was granted and assigned to Clarus Therapeutics on July, 2013 by the United States Patent and Trademark Office.		Clarus Therapeutics		United States Patent and Trademark Office	8492369	July 23, 2013
	‌ US Patent 8828428 Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same	Patent 8828428 was granted and assigned to Clarus Therapeutics on September, 2014 by the United States Patent and Trademark Office.	Clarus Therapeutics	Clarus Therapeutics		United States Patent and Trademark Office	8828428	September 9, 2014
	‌ US Patent 10543219 Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same	Patent 10543219 was granted and assigned to Clarus Therapeutics on January, 2020 by the United States Patent and Trademark Office.	Clarus Therapeutics	Clarus Therapeutics		United States Patent and Trademark Office	10543219	January 28, 2020
	‌ US Patent 11179402 Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same	Patent 11179402 was granted and assigned to Clarus Therapeutics on November, 2021 by the United States Patent and Trademark Office.	Clarus Therapeutics	Clarus Therapeutics		United States Patent and Trademark Office	11179402	November 23, 2021
	‌ US Patent 11179403 Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same	Patent 11179403 was granted and assigned to Clarus Therapeutics on November, 2021 by the United States Patent and Trademark Office.	Clarus Therapeutics	Clarus Therapeutics		United States Patent and Trademark Office	11179403	November 23, 2021
	‌ US Patent 10617696 Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same	Patent 10617696 was granted and assigned to Clarus Therapeutics on April, 2020 by the United States Patent and Trademark Office.	Clarus Therapeutics	Clarus Therapeutics		United States Patent and Trademark Office	10617696	April 14, 2020
	‌ US Patent 8778917 Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same	Patent 8778917 was granted and assigned to Clarus Therapeutics on July, 2014 by the United States Patent and Trademark Office.	Clarus Therapeutics	Clarus Therapeutics		United States Patent and Trademark Office	8778917	July 15, 2014
	‌ US Patent 8778916 Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same	Patent 8778916 was granted and assigned to Clarus Therapeutics on July, 2014 by the United States Patent and Trademark Office.		Clarus Therapeutics		United States Patent and Trademark Office	8778916	July 15, 2014

12 results

0 selected

12 results

0 selected